custirsen sodium
Term · Oncology and biomedicine · MLC-T-ONC-002195
A substance being studied in the treatment of cancer. It blocks the production of a protein called clusterin, which helps cells live longer. This may kill cancer cells that need clusterin to grow. It may also make cells more sensitive to anticancer drugs. It is a type of antisense oligonucleotide, and a type of chemosensitizing agent. Also called OGX-011.
The eicosasodium salt of a mixed-backbone antisense oligodeoxynucleotide with chemosensitizing properties. Custirsen inhibits testosterone-repressed prostate message-2 (TRPM-2). Administration of custirsen abrogates the anti-apoptotic effect of TRPM-2, thereby sensitizing cells to chemotherapy and resulting in tumor cell death. TRPM-2 is an anti-apoptotic clusterin that is overexpressed by prostate cancer cells and is associated with chemoresistance.
| Identifier | MLC-T-ONC-002195 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | OGX-011; clusterin antisense oligonucleotide; antisense TRPM-2; antisense testosterone-repressed prostate message 2; TRPM-2 antisense |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-002195",
"term": "custirsen sodium",
"field": "Oncology and biomedicine",
"definitions": [
"A substance being studied in the treatment of cancer. It blocks the production of a protein called clusterin, which helps cells live longer. This may kill cancer cells that need clusterin to grow. It may also make cells more sensitive to anticancer drugs. It is a type of antisense oligonucleotide, and a type of chemosensitizing agent. Also called OGX-011.",
"The eicosasodium salt of a mixed-backbone antisense oligodeoxynucleotide with chemosensitizing properties. Custirsen inhibits testosterone-repressed prostate message-2 (TRPM-2). Administration of custirsen abrogates the anti-apoptotic effect of TRPM-2, thereby sensitizing cells to chemotherapy and resulting in tumor cell death. TRPM-2 is an anti-apoptotic clusterin that is overexpressed by prostate cancer cells and is associated with chemoresistance."
],
"synonyms": [
"OGX-011",
"clusterin antisense oligonucleotide",
"antisense TRPM-2",
"antisense testosterone-repressed prostate message 2",
"TRPM-2 antisense"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/custirsen-sodium/"
}
Record 5,523 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.